126 related articles for article (PubMed ID: 4053606)
21. Effect of the intrauterine contraceptive device on protein components of human uterine fluid.
Tauber PF; Cramer GM; Zaneveld LJ
Contraception; 1993 Nov; 48(5):494-512. PubMed ID: 8275697
[TBL] [Abstract][Full Text] [Related]
22. The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.
Wollen AL; Sandvei R; Skare A; Justesen NP
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):195-9. PubMed ID: 8122497
[TBL] [Abstract][Full Text] [Related]
23. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
[TBL] [Abstract][Full Text] [Related]
24. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
25. Influence of the copper IUD and the Lippes loop on sperm migration in the human cervical mucus.
Hefnawi F; Kandil O; Askalani H; Serour G
Contraception; 1975 May; 11(5):541-7. PubMed ID: 1139941
[TBL] [Abstract][Full Text] [Related]
26. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
27. Immuno and histochemical study of endometrium in women using copper IUCD.
Mousa MA; El-mekkawi TM; Abdel Aziz AA; El-saharty MF
Popul Sci; 1985; 6():41-50. PubMed ID: 12349093
[TBL] [Abstract][Full Text] [Related]
28. Humoral immune response in women using intrauterine contraceptive device.
Chandra M; Aggarwal S; Sachdeva S; Nayar M; Nayar VL
Indian J Med Res; 1986 Jan; 83():13-8. PubMed ID: 3699864
[No Abstract] [Full Text] [Related]
29. [Copper in the menstrual and physiological cycle cervical mucus of copper IUD users (author's transl)].
Ros A; Bouche M; Adami L; Mancaniello L
Contracept Fertil Sex (Paris); 1980 Jan; 8(1):11-6. PubMed ID: 12336140
[TBL] [Abstract][Full Text] [Related]
30. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
31. Malonaldehyde in cervical mucus associated with copper IUD.
Bond AM; Briggs MH; Deprez PP; Jones RD; Wallace GG
Lancet; 1980 May; 1(8177):1087-8. PubMed ID: 6103422
[TBL] [Abstract][Full Text] [Related]
32. Effects of contraceptive pills and intrauterine devices on urinary bladder.
Zahran MM; Osman MI; Kamel M; Fayad M; Mooro H; Youssef AF
Urology; 1976 Dec; 8(6):567-74. PubMed ID: 793141
[TBL] [Abstract][Full Text] [Related]
33. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
Horwitt MK; Harvey CC; Dahm CH
Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
[TBL] [Abstract][Full Text] [Related]
34. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
35. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
Larsson B; Rodau S; Patek E
Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulins, proteinase inhibitors, albumin, and lysozyme in human cervical mucus. I. Communication: hormonal profiles and cervical mucus changes--methods and results.
Schumacher GF; Kim MH; Hosseinian AH; Dupon C
Am J Obstet Gynecol; 1977 Nov; 129(6):629-36. PubMed ID: 72503
[TBL] [Abstract][Full Text] [Related]
37. [Serum immunoglobulin levels in women fitted with a copper T intrauterine contraceptive device (author's transl)].
Tatra G; Beck A; Prunner Ch; Breitenecker G
Wien Klin Wochenschr; 1975 Oct; 87(20):681-3. PubMed ID: 1220268
[TBL] [Abstract][Full Text] [Related]
38. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
Souza JP; Andrade AT; Pizarro E
Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
[TBL] [Abstract][Full Text] [Related]
39. The influence of different copper wires on human sperm penetration into bovine cervical mucus, in vitro.
Shoham Z; Lidor A; Megory E; Lunenfeld B; Blankstein J; Weissenberg R
Contraception; 1987 Sep; 36(3):327-34. PubMed ID: 3677677
[TBL] [Abstract][Full Text] [Related]
40. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
Fylling P; Fagerhol M
Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
